Clinicians in Conversation: Tackling AMR is not a zero sum game
Description
Collaboration and clinical research are critical in combating the global antimicrobial resistance (AMR) threat. The challenges are many but with growing recognition of this world-wide issue comes hope.
In this podcast you will hear how the global research community is coming together to tackle the problem on multiple fronts by taking a much broader view on AMR. Antibiotic stewardship, vaccines, better public health and new diagnostics all have a role to play.
You will also hear how the NIHR plans to play its part by establishing innovative platform trials, which will help to accelerate research into drug resistance and development of new antimicrobial agents. This approach, tried and tested in the COVID-19 pandemic, will create new opportunities for academic researchers and the life science industry to work smarter, faster and more collaboratively.
The views and opinions expressed in this podcast are those of the host and guests and do not necessarily reflect those of the NIHR or the Department of Health and Social Care.
Transcript: https://docs.google.com/document/d/135jA6ncSn8UlsMa3H5vIHq_cYdLSqo9NJH6gTjRBPsk/edit
United States
